 Bone Diseases, Metabolic
"Bone Diseases, Metabolic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D001851
|
| MeSH Number(s) |
C05.116.198
|
| Concept/Terms |
Bone Diseases, Metabolic- Bone Diseases, Metabolic
- Metabolic Bone Diseases
- Bone Disease, Metabolic
- Disease, Metabolic Bone
- Diseases, Metabolic Bone
- Metabolic Bone Disease
|
Below are MeSH descriptors whose meaning is more general than "Bone Diseases, Metabolic".
Below are MeSH descriptors whose meaning is more specific than "Bone Diseases, Metabolic".
This graph shows the total number of publications written about "Bone Diseases, Metabolic" by people in this website by year, and whether "Bone Diseases, Metabolic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 | | 2006 | 1 | 0 | 1 | | 2007 | 1 | 0 | 1 | | 2012 | 2 | 0 | 2 | | 2016 | 1 | 0 | 1 | | 2017 | 1 | 0 | 1 | | 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Bone Diseases, Metabolic" by people in Profiles.
-
VanSickle JS, Srivastava T, Alon US. Use of calcimimetics in children with normal kidney function. Pediatr Nephrol. 2019 03; 34(3):413-422.
-
Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017 09; 122(1-2):4-17.
-
Job F, Mizumoto S, Smith L, Couser N, Brazil A, Saal H, Patterson M, Gibson MI, Soden S, Miller N, Thiffault I, Saunders C, Yamada S, Hoffmann K, Sugahara K, Farrow E. Functional validation of novel compound heterozygous variants in B3GAT3 resulting in severe osteopenia and fractures: expanding the disease phenotype. BMC Med Genet. 2016 Nov 21; 17(1):86.
-
Sebestyen JF, Srivastava T, Alon US. Bisphosphonates use in children. Clin Pediatr (Phila). 2012 Nov; 51(11):1011-24.
-
Rush ET, DeHaai K, Kreikemeier RM, Lutz RE. Evaluation and comparison of safety, convenience and cost of administering intravenous pamidronate infusions to children in the home and ambulatory care settings. J Pediatr Endocrinol Metab. 2012; 25(5-6):493-7.
-
Grundberg E, Akesson K, Kindmark A, Gerdhem P, Holmberg A, Mellstr?m D, Ljunggren O, Orwoll E, Mallmin H, Ohlsson C, Br?ndstr?m H. The impact of estradiol on bone mineral density is modulated by the specific estrogen receptor-alpha cofactor retinoblastoma-interacting zinc finger protein-1 insertion/deletion polymorphism. J Clin Endocrinol Metab. 2007 Jun; 92(6):2300-6.
-
Waterhouse KM, Auron A, Srivastava T, Haney C, Alon US. Sustained beneficial effect of intravenous bisphosphonates after their discontinuation in children. Pediatr Nephrol. 2007 Feb; 22(2):282-7.
-
Srivastava T, Alon US. The role of bisphosphonates in diseases of childhood. Eur J Pediatr. 2003 Nov; 162(11):735-51.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|